RSS feed

Publications by Oddvar Stokke

139 publications found

Original articles

Michelsen AE, Wergeland R, Stokke O, Brosstad F (2005)
Development of a time-resolved immunofluorometric assay for quantifying platelet-derived microparticles in human plasma
Thromb Res, 117 (6), 705-11
DOI 10.1016/j.thromres.2005.05.024, PubMed 15990159

Hognestad A, Aukrust P, Wergeland R, Stokke O, Gullestad L, Semb AG, Holm T, Andreassen AK, Kjekshus JK (2004)
Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation
Clin Cardiol, 27 (4), 199-203
DOI 10.1002/clc.4960270405, PubMed 15119693

Hognestad A, Endresen K, Wergeland R, Stokke O, Geiran O, Holm T, Simonsen S, Kjekshus JK, Andreassen AK (2003)
Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients
J Am Coll Cardiol, 42 (3), 477-82
DOI 10.1016/s0735-1097(03)00645-4, PubMed 12906976

Oyen O, Wergeland R, Bentdal O, Hartmann A, Brekke IB, Stokke O (2001)
Serial ultrasensitive CRP measurements may be useful in rejection diagnosis after kidney transplantation
Transplant Proc, 33 (4), 2481-3
DOI 10.1016/s0041-1345(01)02070-x, PubMed 11406220

Stokke O (2001)
[Refsum disease--rare, but world-famous]
Tidsskr Nor Laegeforen, 121 (3), 334-5
PubMed 11242878

Wergeland R, Oyen O, Bentdal O, Stokke O (1999)
MicroCRP: a highly sensitive CRP method applied in the monitoring of renal allograft recipients
Scand J Clin Lab Invest, 59 (6), 405-16
DOI 10.1080/00365519950185427, PubMed 10612551

Holmström H, Hall C, Stokke O, Lindberg H, Thaulow E (1999)
[Measurements of N-terminal proatrial natriuretic factor in children]
Tidsskr Nor Laegeforen, 119 (19), 2838-41
PubMed 10494207

Holmström H, Hall C, Stokke O, Lindberg H, Thaulow E (1999)
Elevation of atrial natriuretic peptide prohormone. Hemodynamic background of the elevation of N-terminal natriuretic peptide prohormone in children with congenital heart disease
Cardiol Young, 9 (2), 141-9
DOI 10.1017/s1047951100008350, PubMed 10323511

Bergan S, Rugstad HE, Bentdal O, Sødal G, Hartmann A, Leivestad T, Stokke O (1998)
Monitored high-dose azathioprine treatment reduces acute rejection episodes after renal transplantation
Transplantation, 66 (3), 334-9
DOI 10.1097/00007890-199808150-00010, PubMed 9721802

Jansen GA, Ferdinandusse S, Skjeldal OH, Stokke O, de Groot CJ, Jakobs C, Wanders RJ (1998)
Molecular basis of Refsum disease: identification of new mutations in the phytanoyl-CoA hydroxylase cDNA
J Inherit Metab Dis, 21 (3), 288-91
DOI 10.1023/a:1005388710197, PubMed 9686377

Jansen GA, Ofman R, Ferdinandusse S, Ijlst L, Muijsers AO, Skjeldal OH, Stokke O, Jakobs C, Besley GT, Wraith JE, Wanders RJ (1997)
Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene
Nat Genet, 17 (2), 190-3
DOI 10.1038/ng1097-190, PubMed 9326940

Bergan S, Bentdal O, Sødal G, Brun A, Rugstad HE, Stokke O (1997)
Patterns of azathioprine metabolites in neutrophils, lymphocytes, reticulocytes, and erythrocytes: relevance to toxicity and monitoring in recipients of renal allografts
Ther Drug Monit, 19 (5), 502-9
DOI 10.1097/00007691-199710000-00003, PubMed 9357091

Bergan S, Rugstad HE, Klemetsdal B, Giverhaug T, Bentdal O, Sødal G, Hartmann A, Aarbakke J, Stokke O (1997)
Possibilities for therapeutic drug monitoring of azathioprine: 6-thioguanine nucleotide concentrations and thiopurine methyltransferase activity in red blood cells
Ther Drug Monit, 19 (3), 318-26
DOI 10.1097/00007691-199706000-00013, PubMed 9200774

Holmström H, Thaulow E, Stokke O, Lindberg H, Hall C (1996)
Serum N-terminal proatrial natriuretic factor in children with congenital heart disease
Eur Heart J, 17 (11), 1737-46
DOI 10.1093/oxfordjournals.eurheartj.a014759, PubMed 8922924

Thoresen SI, Wergeland R, Mørkrid L, Stokke O (1996)
Evaluation of an enzymatic immunoassay for free thyroxine determination in canine serum
Vet Res Commun, 20 (5), 411-20
DOI 10.1007/BF00419178, PubMed 8908721

Bergan S, Rugstad HE, Bentdal O, Sødal G, Hartmann A, Klemetsdal B, Aarbakke J, Stokke O (1995)
Optimization of azathioprine therapy by measuring 6-thioguanine nucleotides and methylated mercaptopurine in renal allograft recipients
Transplant Proc, 27 (6), 3426
PubMed 8540033

Strømme P, Stokke O, Jellum E, Skjeldal OH, Baumgartner R (1995)
Atypical methylmalonic aciduria with progressive encephalopathy, microcephaly and cataract in two siblings--a new recessive syndrome?
Clin Genet, 48 (1), 1-5
DOI 10.1111/j.1399-0004.1995.tb04045.x, PubMed 7586637

Bergan S, Rugstad HE, Bentdal O, Stokke O (1994)
Monitoring of azathioprine treatment by determination of 6-thioguanine nucleotide concentrations in erythrocytes
Transplantation, 58 (7), 803-8
PubMed 7940715

Nordsletten L, Kaastad TS, Obrant KJ, Skjeldal S, Kirkeby OJ, Stokke O, Ekeland A (1994)
Muscle contraction increases the in vivo structural strength to the same degree in osteopenic and normal rat tibiae
J Bone Miner Res, 9 (5), 679-85
DOI 10.1002/jbmr.5650090513, PubMed 8053397

Bergan S, Rugstad HE, Bentdal O, Endresen L, Stokke O (1994)
Kinetics of mercaptopurine and thioguanine nucleotides in renal transplant recipients during azathioprine treatment
Ther Drug Monit, 16 (1), 13-20
DOI 10.1097/00007691-199402000-00002, PubMed 8160249

Bergan S, Rugstad HE, Stokke O, Bentdal O, Frøysaker T, Bergan A (1993)
Cyclosporine A monitoring in patients with renal, cardiac, and liver transplants: a comparison between fluorescence polarization immunoassay and two different RIA methods
Scand J Clin Lab Invest, 53 (5), 471-7
DOI 10.1080/00365519309092542, PubMed 8210969

Halse J, Nordal KP, Knudtzon J, Stokke O, Glattre E (1993)
[Bone mineral density and occurrence of fractures in 66-year old women in Oslo]
Tidsskr Nor Laegeforen, 113 (15), 1846-8
PubMed 8322323

Stokke HP, Fauchald P, Holme I, Rugstad HE, Christophersen BO, Stokke O (1993)
[Doxazosin (Carduran)--a research survey]
Tidsskr Nor Laegeforen, 113 (6), 693-9
PubMed 8465331

Christensen E, Woldseth B, Hagve TA, Poll-The BT, Wanders RJ, Sprecher H, Stokke O, Christophersen BO (1993)
Peroxisomal beta-oxidation of polyunsaturated long chain fatty acids in human fibroblasts. The polyunsaturated and the saturated long chain fatty acids are retroconverted by the same acyl-CoA oxidase
Scand J Clin Lab Invest Suppl, 215, 61-74
DOI 10.3109/00365519309090698, PubMed 8327852

STOKKE O (1993)
NORWEGIAN DEVELOPMENT COOPERATION TOWARDS THE YEAR 2000 - DIRECTION AND NORMS
Int. Polit.-Oslo, 51 (1), 91-114

Endresen L, Lie SO, Storm-Mathisen I, Rugstad HE, Stokke O (1990)
Pharmacokinetics of oral 6-mercaptopurine: relationship between plasma levels and urine excretion of parent drug
Ther Drug Monit, 12 (3), 227-34
DOI 10.1097/00007691-199005000-00003, PubMed 2349605

Poll-The BT, Skjeldal OH, Stokke O, Demaugre F, Saudubray JM (1990)
Complementation analysis of peroxisomal disorders and classical Refsum
Prog Clin Biol Res, 321, 537-43
PubMed 1691507

Boberg KM, Smith-Kielland I, Stabursvik A, Stokke O (1989)
Difference in cytotoxicity of (22R)-cholest-5-ene-3 beta,7 alpha,22-triol and (22R)-cholest-5-ene-3 beta,7 beta,22-triol is not explained by different patterns of metabolites
J Steroid Biochem, 33 (6), 1087-9
DOI 10.1016/0022-4731(89)90413-5, PubMed 2615353

Boberg KM, Stabursvik A, Björkhem I, Stokke O (1989)
Dehydroxylation of a 7 beta-hydroxy-C27 plant sterol in rat liver
Biochim Biophys Acta, 1004 (3), 321-6
DOI 10.1016/0005-2760(89)90079-9, PubMed 2758026

Sykulski R, Keller N, Storm T, Stokke O, Myhre T, Himanen P, Quitzau K (1989)
Double-blind comparison of tiapamil and atenolol in patients with mild to moderate hypertension: a multicenter trial
Cardiovasc Drugs Ther, 3 (3), 427-31
DOI 10.1007/BF01858114, PubMed 2487539

Jellum E, Thoresen O, Horn L, Seip R, Nilsen E, Kvittingen EA, Stokke O (1989)
Advances in the use of computerized gas chromatography-mass spectrometry and high-performance liquid chromatography with rapid scanning detection for clinical diagnosis
J Chromatogr, 468, 43-53
DOI 10.1016/s0021-9673(00)96304-0, PubMed 2499586

Poll-The BT, Skjeldal OH, Stokke O, Poulos A, Demaugre F, Saudubray JM (1989)
Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders
Hum Genet, 81 (2), 175-81
DOI 10.1007/BF00293897, PubMed 2463966

Høeg V, Schrumpf E, Blomhoff JP, Frøland S, Rollag H, Stokke O, Aasen AO (1988)
[Etiology of chronic pancreatitis]
Tidsskr Nor Laegeforen, 108 (31), 2834-7
PubMed 3201447

Skjeldal OH, Nyberg-Hansen R, Stokke O (1988)
Neurological disorders and phytanic acid metabolism
Acta Neurol Scand, 78 (4), 324-8
DOI 10.1111/j.1600-0404.1988.tb03664.x, PubMed 3223227

Jellum E, Kvittingen EA, Stokke O (1988)
Mass spectrometry in diagnosis of metabolic disorders
Biomed Environ Mass Spectrom, 16 (1-12), 57-62
DOI 10.1002/bms.1200160111, PubMed 3242708

Torvik A, Torp S, Kase BF, Ek J, Skjeldal O, Stokke O (1988)
Infantile Refsum's disease: a generalized peroxisomal disorder. Case report with postmortem examination
J Neurol Sci, 85 (1), 39-53
DOI 10.1016/0022-510x(88)90034-2, PubMed 2455020

Skjeldal OH, Stokke O (1988)
Evidence against alpha-hydroxyphytanic acid as an intermediate in the metabolism of phytanic acid
Scand J Clin Lab Invest, 48 (1), 97-102
DOI 10.3109/00365518809085400, PubMed 2464193

Skjeldal OH, Stokke O (1987)
The subcellular localization of phytanic acid oxidase in rat liver
Biochim Biophys Acta, 921 (1), 38-42
DOI 10.1016/0005-2760(87)90167-6, PubMed 3620488

Skjeldal OH, Stokke O, Refsum S, Norseth J, Petit H (1987)
Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation
J Neurol Sci, 77 (1), 87-96
DOI 10.1016/0022-510x(87)90209-7, PubMed 2433405

Aakhus T, Stokke O, Stormorken H, Berg KJ, Dahlstrøm K (1987)
Pharmacologic effects of iopentol after intravenous injection in healthy volunteers. Preliminary report
Acta Radiol Suppl, 370, 109-12
PubMed 2980303

Kvittingen EA, Guldal G, Børsting S, Skalpe IO, Stokke O, Jellum E (1986)
N-acetylaspartic aciduria in a child with a progressive cerebral atrophy
Clin Chim Acta, 158 (3), 217-27
DOI 10.1016/0009-8981(86)90285-8, PubMed 3769199

Skjeldal OH, Stokke O, Norseth J, Lie SO (1986)
Phytanic acid oxidase activity in cultured skin fibroblasts. Diagnostic usefulness and limitations
Scand J Clin Lab Invest, 46 (3), 283-7
DOI 10.3109/00365518609083671, PubMed 2424078

Hysing ES, Kofstad J, Lilleaasen P, Stokke O (1986)
Ionized calcium in plasma during cardiopulmonary bypass
Scand J Clin Lab Invest Suppl, 184, 119-23
PubMed 3473609

JELLUM E, HORN L, THORESEN O, KVITTINGEN EA, STOKKE O (1986)
URINARY-EXCRETION OF N-ACETYL AMINO-ACIDS IN PATIENTS WITH SOME INBORN-ERRORS OF AMINO-ACID-METABOLISM
Scand. J. Clin. Lab. Invest., 46 184, 21-26

Jellum E, Horn L, Thoresen O, Kvittingen EA, Stokke O (1986)
Urinary excretion of N-acetyl amino acids in patients with some inborn errors of amino acid metabolism
Scand J Clin Lab Invest Suppl, 184, 21-6
PubMed 3473611

Kvittingen EA, Jellum E, Stokke O, Flatmark A, Bergan A, Sødal G, Halvorsen S, Schrumpf E, Gjone E (1986)
Liver transplantation in a 23-year-old tyrosinaemia patient: effects on the renal tubular dysfunction
J Inherit Metab Dis, 9 (2), 216-24
DOI 10.1007/BF01799465, PubMed 3091928

HYSING ES, KOFSTAD J, LILLEAASEN P, STOKKE O (1986)
IONIZED CALCIUM IN PLASMA DURING CARDIOPULMONARY BYPASS
Scand. J. Clin. Lab. Invest., 46 184, 119-123

STOKKE O, SKJELDAL OH, HOIE K (1986)
DISORDERS RELATED TO THE METABOLISM OF PHYTANIC ACID
Scand. J. Clin. Lab. Invest., 46 184, 3-10

Jellum E, Kvittingen EA, Thoresen O, Guldal G, Horn L, Seip R, Stokke O (1986)
Systematic laboratory diagnosis of human metabolic disorders
Scand J Clin Lab Invest Suppl, 184, 11-20
PubMed 3473607

JELLUM E, KVITTINGEN EA, THORESEN O, GULDAL G, HORN L, SEIP R, STOKKE O (1986)
SYSTEMATIC LABORATORY DIAGNOSIS OF HUMAN METABOLIC DISORDERS
Scand. J. Clin. Lab. Invest., 46 184, 11-20

Westheim A, Simonsen K, Schamaun O, Müller O, Stokke O, Teisberg P (1985)
Effect of exercise training in patients with essential hypertension
J Hypertens Suppl, 3 (3), S479-81
PubMed 2856772

Gundersen T, Kjekshus J, Stokke O, Pedersen T (1985)
Timolol maleate and HDL cholesterol after myocardial infarction
Eur Heart J, 6 (10), 840-4
DOI 10.1093/oxfordjournals.eurheartj.a061770, PubMed 3908104

Kvittingen EA, Børresen AL, Stokke O, van der Hagen CB, Lie SO (1985)
Deficiency of fumarylacetoacetase without hereditary tyrosinemia
Clin Genet, 27 (6), 550-4
DOI 10.1111/j.1399-0004.1985.tb02039.x, PubMed 4017276

Reed RK, Lilleaasen P, Lindberg H, Stokke O (1985)
Dextran 70 versus donor plasma as colloid in open-heart surgery under extreme haemodilution
Scand J Clin Lab Invest, 45 (3), 269-74
DOI 10.3109/00365518509161005, PubMed 2408319

Stokke O, Jellum E (1985)
Diagnosis and studies of metabolic disorders using a multicomponent analytical system
Prog Clin Biol Res, 177, 251-61
PubMed 4011603

Koppang HS, Stene T, Solheim T, Larheim TA, Winsnes A, Monn E, Stokke O (1984)
Dental features in congenital persistent renal tubular acidosis of proximal type
Scand J Dent Res, 92 (6), 489-95
DOI 10.1111/j.1600-0722.1984.tb01287.x, PubMed 6597532

Lundar T, Stokke O (1983)
Total creatine kinase activity in cerebrospinal fluid as an indicator of brain damage during open-heart surgery
Scand J Thorac Cardiovasc Surg, 17 (2), 157-61
DOI 10.3109/14017438309109881, PubMed 6604311

Stokke O, Marstein S, Jellum E, Lie SO (1982)
Accumulation of pyroglutamic acid (5-oxoproline) in homocystinuria
Scand J Clin Lab Invest, 42 (4), 361-9
PubMed 7134819

Stokke O (1982)
Clinical chemical changes in physical activity
Scand J Soc Med Suppl, 29, 93-101
PubMed 6958061

STOKKE O (1982)
CLINICAL CHEMICAL-CHANGES IN PHYSICAL-ACTIVITY
Scand. J. Soc. Med. (29), 93-101

Strømme SB, Frey H, Harlem OK, Stokke O, Vellar OD, Aarø LE, Johnsen JE (1982)
Physical activity and health
Scand J Soc Med Suppl, 29, 9-36
PubMed 6958060

Kvittingen EA, Jellum E, Stokke O (1981)
Assay of fumarylacetoacetate fumarylhydrolase in human liver-deficient activity in a case of hereditary tyrosinemia
Clin Chim Acta, 115 (3), 311-9
DOI 10.1016/0009-8981(81)90244-8, PubMed 7296877

Hørven I, Lilleaasen P, Aasen A, Thoresen O, Stokke O (1981)
Intra-ocular pressure before, during and after extracorporeal circulation in pigs
Scand J Thorac Cardiovasc Surg, 15 (3), 269-72
DOI 10.3109/14017438109100585, PubMed 7347897

Hørven I, Lundar T, Lilleaasen P, Hysing E, Stokke O (1981)
The effect of haemodilution on arterial blood pressure, central venous pressure, intracranial and intra-ocular pressures in pigs
Scand J Thorac Cardiovasc Surg, 15 (3), 273-7
DOI 10.3109/14017438109100586, PubMed 7347898

Stokke O (1980)
[Clinico-chemical changes in physical activity]
Tidsskr Nor Laegeforen, 100 (12B), 776-82
PubMed 7404519

Oseid S, Strømme SB, Frey H, Harlem OK, Stokke O, Vellar OD, Aarø LE, Johnsen JE (1980)
[Physical activity and health]
Tidsskr Nor Laegeforen, 100 (12B), 727-46
PubMed 7404508

Winsnes A, Monn E, Stokke O, Feyling T (1979)
Congenital persistent proximal type renal tubular acidosis in two brothers
Acta Paediatr Scand, 68 (6), 861-8
DOI 10.1111/j.1651-2227.1979.tb08224.x, PubMed 44068

Lilleaasen P, Stokke O (1979)
Moderate and extreme haemodilution in open-heart surgery: electrolytes, urea, creatinine and osmolality
Scand J Clin Lab Invest, 39 (2), 125-32
DOI 10.1080/00365517909106084, PubMed 523960

Lilleaasen P, Stokke O (1979)
Moderate and extreme haemodilution in open-heart surgery: evaluation of haemolysis, cell damage and protein changes
Scand J Clin Lab Invest, 39 (2), 133-41
DOI 10.3109/00365517909106085, PubMed 523961

Halvorsen S, Stokke O, Jellum E (1979)
A variant form of 2-methyl-3-hydroxybutyric and 2-methylacetoacetic aciduria
Acta Paediatr Scand, 68 (1), 123-8
DOI 10.1111/j.1651-2227.1979.tb04972.x, PubMed 758725

Lilleaasen P, Stokke O, Thoresen O, Aasen A, Engesaeter L, Frøysaker T (1979)
Effects of different non-haemic fluids in open-heart surgery. An experimental study in the pig
Scand J Thorac Cardiovasc Surg, 13 (3), 233-40
DOI 10.3109/14017437909100557, PubMed 542826

Størset P, Stokke O, Jellum E (1978)
Monosaccharides and monosaccharide derivatives in human seminal plasma
J Chromatogr, 145 (3), 351-7
DOI 10.1016/s0378-4347(00)81364-x, PubMed 659523

Brown GK, Stokke O, Jellum E (1978)
Chromatographic profile of high boiling point organic acids in human urine
J Chromatogr, 145 (2), 177-84
DOI 10.1016/s0378-4347(00)81337-7, PubMed 649712

Lilleaasen P, Stokke O (1978)
Moderate and extreme hemodilution in open-heart surgery: fluid balance and acid-base studies
Ann Thorac Surg, 25 (2), 127-33
DOI 10.1016/s0003-4975(10)63505-9, PubMed 343739

Lilleaasen P, Frøysaker T, Stokke O (1978)
Cardiac surgery in extreme haemodilution without donor blood, blood products or artificial macromolecules
Scand J Thorac Cardiovasc Surg, 12 (3), 249-51
PubMed 310160

Goodman SI, Helland P, Stokke O, Flatmark A, Jellum E (1977)
Organic acid profiles of human tissue biopsies by capillary gas chromatography-mass spectrometry
J Chromatogr, 142, 497-503
DOI 10.1016/s0021-9673(01)92062-x, PubMed 914931

Jellum E, Storseth P, Alexander J, Helland P, Stokke O, Teig E (1976)
Application of glass capillary-column gas chromatography-mass spectrometry to the studies of human diseases
J Chromatogr, 126, 487-93
DOI 10.1016/s0021-9673(01)84095-4, PubMed 789388

Stokke O, Goodman SI, Moe PG (1976)
Inhibition of brain glutamate decarboxylase by glutarate, glutaconate, and beta-hydroxyglutarate: explanation of the symptoms in glutaric aciduria?
Clin Chim Acta, 66 (3), 411-5
DOI 10.1016/0009-8981(76)90241-2, PubMed 1248144

Stokke O, Goodman SI, Thompson JA, Miles BS (1975)
Glutaric aciduria; presence of glutaconic and beta-hydroxyglutaric acids in urine
Biochem Med, 12 (4), 386-91
DOI 10.1016/0006-2944(75)90071-x, PubMed 1164416

Stokke O (1974)
Preservation of gamma-glutamyl transpeptidase activity in human urine
Clin Chim Acta, 57 (2), 143-8
DOI 10.1016/0009-8981(74)90422-7, PubMed 4154815

Eldjarn L, Jellum E, Stokke O (1974)
Application of gas chromatography-mass spectrometry in routine and research in clinical chemistry
J Chromatogr, 91, 353-66
DOI 10.1016/s0021-9673(01)97914-2, PubMed 4133390

Eldjarn L, Jellum E, Stokke O (1973)
Pyroglutamic aciduria: rate of formation and degradation of pyroglutamate
Clin Chim Acta, 49 (3), 311-23
DOI 10.1016/0009-8981(73)90227-1, PubMed 4776475

Jellum E, Stokke O, Eldjarn L (1973)
Application of gas chromatography, mass spectrometry, and computer methods in clinical biochemistry
Anal Chem, 46 (7), 1099-106
PubMed 4201587

Stokke O, Jellum E, Eldjarn L, Schnitler R (1973)
The occurrence of beta-hydroxy-n-valeric acid in a patient with propionic and methylmalonic acidemia
Clin Chim Acta, 45 (4), 391-401
DOI 10.1016/0009-8981(73)90040-5, PubMed 4730209

Pettersen JE, Stokke O (1973)
Branched short-chain dicarboxylic acids in human urine
Biochim Biophys Acta, 304 (2), 316-25
DOI 10.1016/0304-4165(73)90250-x, PubMed 4710759

JELLUM E, STOKKE O, ELDJARN L (1973)
APPLICATION OF GAS-CHROMATOGRAPHY, MASS-SPECTROMETRY, AND COMPUTER METHODS IN CLINICAL BIOCHEMISTRY
Anal. Chem., 45 (7), 1099-1106

Eldjarn L, Jellum E, Stokke O (1972)
Pyroglutamic aciduria: studies on the enzymic block and on the metabolic origin of pyroglutamic acid
Clin Chim Acta, 40 (2), 461-76
DOI 10.1016/0009-8981(72)90359-2, PubMed 5056146

Jellum E, Stokke O, Eldjarn L (1972)
Combined use of gas chromatography, mass spectrometry, and computer in diagnosis and studies of metabolic disorders
Clin Chem, 18 (8), 800-9
PubMed 4557757

Stokke O, Eldjarn L, Jellum E, Pande H, Waaler PE (1972)
Beta-methylcrotonyl-CoA carboxylase deficiency: a new metabolic error in leucine degradation
Pediatrics, 49 (5), 726-35
PubMed 5035417

Kluge T, Borresen HC, Jellum E, Stokke O, Eldjarn L, Fretheim B (1972)
Esophageal hiatus hernia and mental retardation: life-threatening postoperative metabolic acidosis and potassium deficiency linked with a new inborn error of nitrogen metabolism
Surgery, 71 (1), 104-9
PubMed 5007568

Jellum E, Stokke O, Eldjarn L (1971)
Screening for metabolic disorders using gas-liquid chromatography, mass spectrometry, and computer technique
Scand J Clin Lab Invest, 27 (3), 273-85
DOI 10.3109/00365517109080219, PubMed 4931892

Skrede S, Strömme JH, Stokke O, Lie SO, Eldjarn L (1971)
Fatal congenital lactic acidosis in two siblings. II. Biochemical studies in vivo and in vitro
Acta Paediatr Scand, 60 (2), 138-45
DOI 10.1111/j.1651-2227.1971.tb06633.x, PubMed 5548118

Stokke O, Bremer J (1970)
A simple method for preparation of methyl-labelled (-) carnitine
Biochim Biophys Acta, 218 (3), 552-4
DOI 10.1016/0005-2760(70)90021-4, PubMed 5499212

Jellum E, Kluge T, Börresen HC, Stokke O, Eldjarn L (1970)
Pyroglutamic aciduria--a new inborn error of metabolism
Scand J Clin Lab Invest, 26 (4), 327-35
DOI 10.3109/00365517009046241, PubMed 5486400

Eldjarn L, Jellum E, Stokke O, Pande H, Waaler PE (1970)
Beta-hydroxyisovaleric aciduria and beta-methylcrotonylglycinuria: a new inborn error of metabolism
Lancet, 2 (7671), 521-2
DOI 10.1016/s0140-6736(70)90140-6, PubMed 4194964

Stokke O (1970)
[Metabolism of methylmalonic acid illustrated by a recently discovered inherited disease]
Tidsskr Nor Laegeforen, 90 (2), 242-5
PubMed 5430196

Halvorsen S, Stokke O, Eldjarn L (1970)
Abnormal patterns of urine and serum amino acids in methylmalonic acidemia
Acta Paediatr Scand, 59 (1), 28-32
DOI 10.1111/j.1651-2227.1970.tb15510.x, PubMed 5422739

Eldjarn L, Refsum S, Stokke O (1970)
Heredopathia atactica polyneuritiformis--an inborn error of lipid metabolism involving the nervous system
Acta Neurol Scand, 46 (S43), 194-6
DOI 10.1111/j.1600-0404.1970.tb02181.x, PubMed 5457822

Stokke O (1969)
Evidence against a CO2-fixation mechanism in the degradation of a beta-methyl-substituted fatty acid in mammals
Biochim Biophys Acta, 176 (2), 230-6
DOI 10.1016/0005-2760(69)90182-9, PubMed 5775945

Stokke O (1969)
The degradation of a branched chain fatty acid by alternations between alpha- and beta-oxidations
Biochim Biophys Acta, 176 (1), 54-9
DOI 10.1016/0005-2760(69)90073-3, PubMed 5766028

Halvorsen S, Stokke O, Eldjarn L (1968)
Methylmalonic-acidaemia-hyperglycinaemia
Lancet, 1 (7545), 756
DOI 10.1016/s0140-6736(68)92208-3, PubMed 4170994

Stokke O (1968)
Alpha-oxidation of a beta-methyl-substituted fatty acid in guinea-pig liver mitochondria
Biochim Biophys Acta, 152 (1), 213-6
DOI 10.1016/0005-2760(68)90024-6, PubMed 5645451

Eldjarn L, Try K, Stokke O (1968)
Studies on the biochemical defect in heredopathia atactica polyneuritiformis (Refsum's disease)
Pathol Eur, 3 (2), 459-67
PubMed 4176999

Stokke O, Try K, Eldjarn L (1967)
Alpha-oxidation as an alternative pathway for the degradation of branched-chain fatty acids in man, and its failure in patients with Refsum's disease
Biochim Biophys Acta, 144 (2), 271-84
DOI 10.1016/0005-2760(67)90157-9, PubMed 4168936

Steinberg D, Mize CE, Avigan J, Fales HM, Eldjarn L, Try K, Stokke O, Refsum S (1967)
Studies on the metabolic error in Refsum's disease
J Clin Invest, 46 (3), 313-22
DOI 10.1172/JCI105533, PubMed 4164676

Eldjarn L, Try K, Stokke O, Munthe-Kaas AW, Refsum S (1967)
Heredopathia atactica polyneuritiformis, biochemical defect and dietary treatment
Acta Neurol Scand, 43 (S31), 61-2
DOI 10.1111/j.1600-0404.1967.tb02058.x, PubMed 4171040

Eldjarn L, Try K, Stokke O (1966)
The existence of an alternative pathway for the degradation of branch-chained fatty acids, and its failure in heredopathia atactica polyneuritiformis (Refsum's disease)
Biochim Biophys Acta, 116 (2), 395-7
DOI 10.1016/0005-2760(66)90023-3, PubMed 4163203

Eldjarn L, Try K, Stokke O, Munthe-Kaas AW, Refsum S, Steinberg D, Avigan J, Mize C (1966)
Dietary effects on serum-phytanic-acid levels and on clinical manifestations in heredopathia atactica polyneuritiformis
Lancet, 1 (7439), 691-3
DOI 10.1016/s0140-6736(66)91632-1, PubMed 4159604

Eldjarn L, Stokke O, Try K (1966)
Alpha-oxidation of branched chain fatty acids in man and its failure in patients with Refsum's disease showing phytanic acid accumulation
Scand J Clin Lab Invest, 18 (6), 694-5
DOI 10.3109/00365516609049057, PubMed 4163668

Eldjarn L, Try K, Stokke O (1966)
The ability of patients with herdopathia atactica polyneuritiformis to alpha-oxidize and degrade several isoprenoid branch-chained fatty structures
Scand J Clin Lab Invest, 18 (2), 141-50
DOI 10.3109/00365516609051810, PubMed 4161956

Eldjarn L, Jellum E, Aas M, Try K, Stokke O (1966)
Synthesis of 2,6,10,14-tetramethylpentadecanoic acid (pristanic acid)
Acta Chem Scand, 20 (8), 2313-4
DOI 10.3891/acta.chem.scand.20-2313, PubMed 5966874

Review articles

Hall C, Stokke O (2002)
[Cardiac natriuretic peptides as markers for cardiac disease--where do we stand today?]
Tidsskr Nor Laegeforen, 122 (29), 2784-6
PubMed 12523146

Stokke O, Skjeldal OH, Høie K (1986)
Disorders related to the metabolism of phytanic acid
Scand J Clin Lab Invest Suppl, 184, 3-10
PubMed 2438746

STROMME SB, FREY H, HARLEM OK, STOKKE O, VELLAR OD, AARO LE, JOHNSEN JE (1982)
PHYSICAL-ACTIVITY AND HEALTH - SUMMARY AND MAIN CONCLUSIONS
Scand. J. Soc. Med. (29), 9-+

Other articles

Hall C, Stokke O, Kjekshus J (1996)
[ProANF and heart failure in general practice]
Tidsskr Nor Laegeforen, 116 (25), 3048
PubMed 8975436

Stokke O (1996)
[Physical therapy without referral]
Tidsskr Nor Laegeforen, 116 (10), 1259-60
PubMed 8658405

Hall C, Aaberge L, Stokke O (1995)
In vitro stability of N-terminal proatrial natriuretic factor in unfrozen samples: an important prerequisite for its use as a biochemical parameter of atrial pressure in clinical routine
Circulation, 91 (3), 911
PubMed 7828325

Stokke O (1992)
[The quackery low prohibits physical therapists from calling themselves specialists]
Tidsskr Nor Laegeforen, 112 (13), 1744-5
PubMed 1509444

Stokke O (1992)
[Uncertain effect of electrotherapy]
Tidsskr Nor Laegeforen, 112 (7), 927-8
PubMed 1557770

Stokke O (1992)
[Medical treatment of back problems--10 times more expensive than treatment by chiropractors]
Tidsskr Nor Laegeforen, 112 (4), 526
PubMed 1532465

Stokke O (1991)
[Chiropractors and backache]
Tidsskr Nor Laegeforen, 111 (8), 1034
PubMed 1828311

Stokke O (1991)
[Is the patient-physician relation affected by ineffective physical treatment?]
Tidsskr Nor Laegeforen, 111 (7), 869
PubMed 2020963

Stokke O (1990)
[Manipulation treatment by physicians, physiotherapists and chiropractors]
Tidsskr Nor Laegeforen, 110 (4), 526-7
PubMed 2309202

Stokke O, Jellum E, Kvittingen EA, Skjeldal O, Hvistendahl G (1986)
Epoxy acids in peroxisomal disorders
Scand J Clin Lab Invest, 46 (1), 95-6
DOI 10.3109/00365518609086487, PubMed 3952444

Stokke O, Skrede S, Ek J, Björkhem I (1984)
Refsum's disease, adrenoleucodystrophy, and the Zellweger syndrome
Scand J Clin Lab Invest, 44 (5), 463-4
DOI 10.3109/00365518409083839, PubMed 6207587

Steinmann B, Gitzelmann R, Kvittingen EA, Stokke O (1984)
Prenatal diagnosis of hereditary tyrosinemia
N Engl J Med, 310 (13), 855-6
DOI 10.1056/NEJM198403293101315, PubMed 6700679

Stokke O, Refsum S (1982)
Refsum's disease and metabolism of phytanic acid
Lancet, 1 (8277), 906-7
DOI 10.1016/s0140-6736(82)92172-9, PubMed 6175864

STOKKE O, HELLAND P (1978)
ANALYSIS OF SULFONIC-ACIDS BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY OF TRIMETHYLSILYL DERIVATIVES
J CHROMATOGR, 146 (1), 132-136
DOI 10.1016/S0378-4347(00)81297-9

Stokke O (1976)
Gas chromatography mass spectrometry in laboratory medicine: viewpoints on the application in the diagnositc routine
Biomed Mass Spectrom, 3 (3), 97-9
DOI 10.1002/bms.1200030302, PubMed 990425

Eldjarn L, Jellum E, Stokke O (1975)
Inborn errors of metabolism--a challenge to the clinical chemist
Clin Chem, 21 (1), 63-6
PubMed 1090395

STOKKE O (1973)
EAST AFRICAN SCENE - KENYA, TANZANIA AND UGANDA, PAST AND PRESENT - NORWEGIAN - BULL,E
Int. Polit.-Oslo (4), 956-957

Books

Stokke O, Hagve TA (2010)
Undersøkelser ved sykdom
Gyldendal akademisk, Oslo, 240 s.
BIBSYS 100971695, ISBN 978-82-05-32366-7

Stokke O, Hagve TA (2006)
Klinisk biokjemi og fysiologi
Gyldendal akademisk, Oslo (3. utg. [i.e. 14. utg.]), 403 s.
BIBSYS 060776838, ISBN 978-82-05-35176-9

Stokke O (2003)
Fra håndverk til høyteknologi: klinisk kjemi på Rikshospitalet fra 1953 til 2003
Rikshospitalet, [Oslo], 447 s.
BIBSYS 032121806

Stokke O (2000)
Klinisk biokjemi og fysiologi
Gyldendal akademisk, Oslo (2. utg. [i.e. 13. utg.]), 389 s.
BIBSYS 000311480, ISBN 82-417-1213-8

Stokke O (1997)
Klinisk biokjemi og fysiologi
Universitetsforl., Oslo ([12. utg.]), 326 s.
BIBSYS 970359276, ISBN 82-00-42963-6

Stokke O (1995)
Klinisk biokjemi og fysiologi
[Institutt for klinisk biokjemi, Rikshospitalet], Oslo ([11. utg.]), 360 s.
BIBSYS 950866148, ISBN 82-7633-062-2

Stokke O (1990)
Klinisk biokjemi og fysiologi: for medisinske studenter
[s.n.], Oslo, 408 s.
BIBSYS 010989617

Theses

Try K, Stokke O (1969)
Biochemical and dietary studies in Refsum's disease <herodopathia atact ica polyneuritiformis>
Universitetsforlaget, Oslo, 1 b. (flere pag.)
BIBSYS 940234149